Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.27 USD | +1.23% | +0.70% | +36.01% |
Jun. 13 | Halozyme Therapeutics Insider Sold Shares Worth $1,006,300, According to a Recent SEC Filing | MT |
Jun. 11 | Halozyme Therapeutics May Seeks M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.01% | 6.4B | |
+14.84% | 121B | |
+18.31% | 112B | |
+1.86% | 22.72B | |
-18.26% | 20.82B | |
-41.55% | 16.36B | |
-14.23% | 16.19B | |
-18.07% | 16.66B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing